Similar articles

• Serological markers predict inflammatory bowel disease years before the diagnosis.

  van Schaik FD, Oldenburg B, Hart AR, Siersema PD, Lindgren S, Grip O, Teucher B, Kaaks R, Bergmann MM, Boeing H, Carbonnel F, Jantchou P, Boutron-Ruault MC, Tjønneland A, Olsen A, Crowe FL, Peeters PH, van Oijen MG, Bueno-de-Mesquita HB. van Schaik FD, et al. Gut. 2013 May;62(5):683-8. doi: 10.1136/gutjnl-2012-302717. Epub 2012 Jul 26. Gut. 2013. PMID: 22842615
• Positive and negative predictive values: use of inflammatory bowel disease serologic markers.

  Austin GL, Shaheen NJ, Sandler RS. Austin GL, et al. Am J Gastroenterol. 2006 Mar;101(3):413-6. doi: 10.1111/j.1572-0241.2006.00475.x. Am J Gastroenterol. 2006. PMID: 16542272 No abstract available.
• Biological markers in inflammatory bowel disease: practical consideration for clinicians.

  Mendoza JL, Abreu MT. Mendoza JL, et al. Gastroenterol Clin Biol. 2009 Jun;33 Suppl 3:S158-73. doi: 10.1016/S0399-8320(09)73151-3. Gastroenterol Clin Biol. 2009. PMID: 20117339
• [Antineutrophil cytoplasmic antibodies (ANCA) in chronic inflammatory intestinal disease].

  García Herola A, Nos Mateu P, Ponce García J. García Herola A, et al. Gastroenterol Hepatol. 2000 Jan;23(1):16-23. Gastroenterol Hepatol. 2000. PMID: 10726379 Review. Spanish. No abstract available.
• [Antineutrophil cytoplasmatic antibodies and their diagnostic significance as serum markers].

  Terjung B, Spengler U, Sauerbruch T. Terjung B, et al. Dtsch Med Wochenschr. 1999 Nov 5;124(44):1314-20. doi: 10.1055/s-2007-1024537. Dtsch Med Wochenschr. 1999. PMID: 10596294 Review. German. No abstract available.